NF
Nareshkumar Fulchand Jain
About Nareshkumar Fulchand Jain
Data last updated:
Nareshkumar Fulchand Jain is a Director at Njbio India Pharmaceutical Private Limited (since 2019). The company operates in Travel and Hospitality. Njbio India Pharmaceutical Private Limited reported revenue of ₹15.20 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Njbio India Pharmaceutical Private Limited U73100MH2019PTC319319 | Director | 10 Jan 2019 | 2019 | ₹15.20 Cr (FY 2025) | Active |
Board colleagues of Nareshkumar Fulchand Jain
| Name | DIN | Company | Designation |
|---|---|---|---|
| Arpit Pokharna | 10087202 | Njbio India Pharmaceutical Private Limited | Director |
| Hetvi Alpesh Sheth | Njbio India Pharmaceutical Private Limited | Company Secretary | |
| Rahul Suresh Bagul | 10869764 | Njbio India Pharmaceutical Private Limited | Whole-Time Director |
| Swati Mathur | Njbio India Pharmaceutical Private Limited | Cfo | |
| Tanveer Fatima | Njbio India Pharmaceutical Private Limited | Company Secretary |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Nareshkumar Fulchand Jain
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Nareshkumar Fulchand Jain
Nareshkumar Fulchand Jain currently holds 1 directorship: Njbio India Pharmaceutical Private Limited (Director, since 10 Jan 2019, revenue ₹15.20 Cr (FY 2025)).
Nareshkumar Fulchand Jain was first appointed on 10 Jan 2019 as Director at Njbio India Pharmaceutical Private Limited.
The current boards of Nareshkumar Fulchand Jain's companies include Arpit Pokharna (Njbio India Pharmaceutical Private Limited), Hetvi Alpesh Sheth (Njbio India Pharmaceutical Private Limited), Rahul Suresh Bagul (Njbio India Pharmaceutical Private Limited), Swati Mathur (Njbio India Pharmaceutical Private Limited), Tanveer Fatima (Njbio India Pharmaceutical Private Limited).